New data collected in a collaborative study between researchers in the U.S. and Japan has found that Botox is largely ineffective as a treatment for chronic migraines. According to a report released Tuesday in the Journal of the American Medical Association, chronic migraine sufferers saw only a slight dip in frequency when using the drug.
Lead researcher Dr. Jeffrey Jackson from the Medical College of Wisconsin in Milwaukee and his team reviewed 27 different studies including over 27,000 migraine patients. For those suffering daily headaches, Botox reduced frequency by one to two days a month. Those with less frequent migraines saw no appreciable change.
"The effect these appear to be having on migraine headaches is small - it only reduces headaches by a couple of days a month," Jackson told msn.com.
For comments and feedback contact: editorial@rttnews.com
Health News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.